2-Fluoro-oestradiol does not cause uterine refractoriness but inhibits oestradiol-induced implantation in rats.
An intravenous injection of 2-fluoro-oestradiol simultaneously with an implantation-inducing dose of oestradiol reduced the number of implantation sites in delayed implanting hypophysectomized rats maintained with progesterone. Administration of 2-fluoro-oestradiol 1 h before or after oestradiol had no effect. Furthermore, injection of as much as 500 ng 2-fluoro-oestradiol 48 h before administration of oestradiol failed to have any effect upon implantation, i.e. failure to block implantation was correlated with failure to induce the uterine refractory state. These results suggest that conversion of primary oestrogens to catechol oestrogens could be important for implantation as well as for the induction of the oestrogen refractory state in the uterus.
Long
S
S
Department of Gynecology & Obstetrics, Ralph L. Smith Research Center, University of Kansas Medical Center, Kansas City 66103.
Dey
S K
SK
Johnson
D C
DC
D000818:Animals; D010064:Embryo Implantation / Q000187:drug effects*; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D007016:Hypophysectomy; D051381:Rats; D014599:Uterus / Q000187:drug effects* / Q000502:physiology
D004967:Estrogens; C037475:2-fluoroestradiol; D004958:Estradiol